Is Global Medical Stock a Good Investment?
Global Medical Investment Advice | GMRE |
- Examine Global Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Global Medical's leadership team and their track record. Good management can help Global Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Diversified REITs space and any emerging trends that could impact Global Medical's business and its evolving consumer preferences.
- Compare Global Medical's performance and market position to its competitors. Analyze how Global Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Global Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Global Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Global Medical REIT stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Global Medical REIT is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Global Medical Stock
Researching Global Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 64.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.22. Some equities with similar Price to Book (P/B) outperform the market in the long run. Global Medical REIT last dividend was issued on the 21st of March 2025. The entity had 1:400 split on the 17th of November 2014.
To determine if Global Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Global Medical's research are outlined below:
| About 64.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Global Medical REITs SWOT analysis healthcare REIT stock faces growth challenges - Investing.com |
Global Medical Quarterly Cash And Short Term Investments |
|
Global Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Global Medical REIT. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Global Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Global Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Global Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-06 | 2024-09-30 | 0.02 | 0.03 | 0.01 | 50 | ||
2024-05-07 | 2024-03-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2023-05-03 | 2023-03-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2022-05-04 | 2022-03-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2022-02-28 | 2021-12-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2021-08-03 | 2021-06-30 | 0.05 | 0.04 | -0.01 | 20 | ||
2021-05-05 | 2021-03-31 | 0.04 | 0.03 | -0.01 | 25 | ||
2020-05-06 | 2020-03-31 | 0.04 | 0.03 | -0.01 | 25 |
Global Medical Target Price Consensus
Global target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Global Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 10 | Strong Buy |
Most Global analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Global stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Global Medical REIT, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGlobal Medical Target Price Projection
Global Medical's current and average target prices are 8.39 and 10.84, respectively. The current price of Global Medical is the price at which Global Medical REIT is currently trading. On the other hand, Global Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Global Medical Market Quote on 25th of March 2025
Target Price
Analyst Consensus On Global Medical Target Price
Global Medical Analyst Ratings
Global Medical's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Global Medical stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Global Medical's financials, market performance, and future outlook by experienced professionals. Global Medical's historical ratings below, therefore, can serve as a valuable tool for investors.Know Global Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Global Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Global Medical REIT backward and forwards among themselves. Global Medical's institutional investor refers to the entity that pools money to purchase Global Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Charles Schwab Investment Management Inc | 2024-12-31 | 877.1 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 845.5 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 751.3 K | Pacific Ridge Capital Partners, Llc | 2024-12-31 | 712.1 K | State Of New Jersey Common Pension Fd D | 2024-12-31 | 637.8 K | Northern Trust Corp | 2024-12-31 | 628.9 K | Phocas Financial Corp | 2024-12-31 | 622.4 K | Man Group Plc | 2024-12-31 | 561 K | Keeley-teton Advisors, Llc | 2024-12-31 | 471.9 K | Vanguard Group Inc | 2024-12-31 | 6.3 M | Blackrock Inc | 2024-12-31 | 5.8 M |
Global Medical's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.15 B.Market Cap |
|
Global Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.19 | 0.20 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.01 | 0.01 |
Determining Global Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Global Medical is a good buy. For example, gross profit margin measures Global Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Global Medical's profitability and make more informed investment decisions.
Please note, the presentation of Global Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Global Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Global Medical's management manipulating its earnings.
Evaluate Global Medical's management efficiency
Global Medical REIT has return on total asset (ROA) of 0.0163 % which means that it generated a profit of $0.0163 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0115 %, meaning that it created $0.0115 on every $100 dollars invested by stockholders. Global Medical's management efficiency ratios could be used to measure how well Global Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Global Medical's Return On Capital Employed is projected to slightly grow based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.01, whereas Return On Equity is forecasted to decline to 0.01. At present, Global Medical's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 666.7 M, whereas Non Current Assets Total are forecasted to decline to about 836.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.43 | 12.68 | |
| Tangible Book Value Per Share | 7.52 | 11.44 | |
| Enterprise Value Over EBITDA | 12.64 | 12.63 | |
| Price Book Value Ratio | 0.95 | 0.91 | |
| Enterprise Value Multiple | 12.64 | 12.63 | |
| Price Fair Value | 0.95 | 0.91 | |
| Enterprise Value | 18 M | 18.9 M |
The strategic initiatives led by Global Medical's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Basic technical analysis of Global Stock
As of the 25th of March, Global Medical retains the Downside Deviation of 1.54, risk adjusted performance of 0.0613, and Market Risk Adjusted Performance of 0.2486. Global Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Global Medical REIT treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Global Medical is priced fairly, providing market reflects its last-minute price of 8.39 per share. Given that Global Medical REIT has jensen alpha of 0.0995, we strongly advise you to confirm Global Medical REIT's regular market performance to make sure the company can sustain itself at a future point.Global Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Global Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Global Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Global Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Global Medical's Outstanding Corporate Bonds
Global Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Global Medical REIT uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Global bonds can be classified according to their maturity, which is the date when Global Medical REIT has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| GLOBAL PARTNERS LP Corp BondUS37954FAG90 | View | |
| US37954FAJ30 Corp BondUS37954FAJ30 | View | |
| US37959EAA01 Corp BondUS37959EAA01 | View | |
| GL 48 15 JUN 32 Corp BondUS37959EAB83 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| US37959GAA58 Corp BondUS37959GAA58 | View | |
| US37959GAC15 Corp BondUS37959GAC15 | View |
Understand Global Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Global Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0613 | |||
| Market Risk Adjusted Performance | 0.2486 | |||
| Mean Deviation | 1.17 | |||
| Semi Deviation | 1.41 | |||
| Downside Deviation | 1.54 | |||
| Coefficient Of Variation | 1577.79 | |||
| Standard Deviation | 1.52 | |||
| Variance | 2.31 | |||
| Information Ratio | 0.0808 | |||
| Jensen Alpha | 0.0995 | |||
| Total Risk Alpha | 0.1478 | |||
| Sortino Ratio | 0.08 | |||
| Treynor Ratio | 0.2386 | |||
| Maximum Drawdown | 6.82 | |||
| Value At Risk | (2.30) | |||
| Potential Upside | 2.99 | |||
| Downside Variance | 2.36 | |||
| Semi Variance | 1.97 | |||
| Expected Short fall | (1.30) | |||
| Skewness | (0.03) | |||
| Kurtosis | 0.4939 |
| Risk Adjusted Performance | 0.0613 | |||
| Market Risk Adjusted Performance | 0.2486 | |||
| Mean Deviation | 1.17 | |||
| Semi Deviation | 1.41 | |||
| Downside Deviation | 1.54 | |||
| Coefficient Of Variation | 1577.79 | |||
| Standard Deviation | 1.52 | |||
| Variance | 2.31 | |||
| Information Ratio | 0.0808 | |||
| Jensen Alpha | 0.0995 | |||
| Total Risk Alpha | 0.1478 | |||
| Sortino Ratio | 0.08 | |||
| Treynor Ratio | 0.2386 | |||
| Maximum Drawdown | 6.82 | |||
| Value At Risk | (2.30) | |||
| Potential Upside | 2.99 | |||
| Downside Variance | 2.36 | |||
| Semi Variance | 1.97 | |||
| Expected Short fall | (1.30) | |||
| Skewness | (0.03) | |||
| Kurtosis | 0.4939 |
Consider Global Medical's intraday indicators
Global Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Global Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 9830.6 | |||
| Daily Balance Of Power | (0.28) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 8.41 | |||
| Day Typical Price | 8.4 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.05) |
Global Medical Corporate Filings
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 12th of August 2024 Other Reports | ViewVerify |
Global Stock media impact
Far too much social signal, news, headlines, and media speculation about Global Medical that are available to investors today. That information is available publicly through Global media outlets and privately through word of mouth or via Global internal channels. However, regardless of the origin, that massive amount of Global data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Global Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Global Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Global Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Global Medical alpha.
Global Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Global Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Global Medical Corporate Directors
| Henry Cole | Lead Independent Director | Profile | |
| Matthew Cypher | Independent Director | Profile | |
| Huiqi Zhang | Director | Profile | |
| Roscoe Moore | Independent Director | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 0.84 | Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth 0.066 |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Global Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.